News

Find News

Filter articles

Applied Filters

Showing 821 to 830 of 832 results

Mylan signs generic truce with Shionogi and Andrx

Japan, US15-03-2013

Generic drug maker Mylan has struck a deal with pharma companies Shionogi and Andrx to resolve a patent dispute over their diabetes drug Fortamet.

Janssen sues Hetero over generic HIV treatment

14-03-2013

Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.

ViiV Healthcare joins patent pool for cheaper AIDS drugs

28-02-2013

ViiV Healthcare, a public health joint venture between GlaxoSmithKline, Shionogi and Pfizer, has signed up to the Medicines Patent Pool (MPP) to provide greater access to affordable AIDS treatments in developing countries.

FDA approves generic heroin substitutes

US26-02-2013

The US Food and Drug Administration has approved two generic versions of Reckitt Benckiser’s heroin replacement tablet Suboxone – despite Reckitt’s claims that the product is unsafe.

BRICK nations catching up on patents, as Brazil looks to life sciences

Brazil, China, India, Russia, South Korea25-02-2013

In a report published by Thomson Reuters on February 20, the BRICK nations were shown to be filing almost as many patents as the G7 nations in 2011.

US appeals court upholds AstraZeneca’s Seroquel XR patent

US19-02-2013Legal developments

The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

Teva faces $2 billion damages for selling generic Protonix

Israel18-02-2013

Israeli company Teva Pharmaceuticals could be forced to pay more than $2 billion in damages for selling a generic version of Nycomed and Pfizer’s heartburn reliever Protonix before the drug’s patent exclusivity expired in the US.

Bristol-Myers Squibb loses Baraclude patent fight with Teva

US14-02-2013

A US judge has declared pharmaceutical company Bristol-Myers Squibb’s patent covering its hepatitis B treatment Baraclude obvious and invalid.

India’s Patent Office revokes Sutent cancer drug patent

India14-02-2013Legal developments

India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.

Mexican Senate proposes bill to reduce life term of medicine patents

Mexico01-02-2013Legal developments

The Mexican Senate has published a bill which, if adopted, will reduce the life term of medicine patents in Mexico by up to one year.

Showing 821 to 830 of 832 results

LSIPR